- Medicine · Sat.
Orzeyful, a twice-daily pill from Takeda for adults with narcolepsy type 1, is now available by prescription after the DEA placed it in Schedule IV. It is the first drug that mimics orexin, the brain chemical people with the disease lose, a cause Stanford’s Emmanuel Mignot helped discover. Takeda has not announced a price.
- Medicine · Sat.
A CDC survey estimates 9.8% of U.S. adults took a GLP-1 medicine such as Ozempic, Wegovy or Zepbound in the past year. Among users, 44% changed how they took it, most often by skipping doses, and 22.6% used a compounded version, which the FDA does not check for safety, effectiveness or quality.
- Profiles · Sat.
Fei-Fei Li, whose ImageNet helped launch modern AI, will become AMD’s chief scientist when the chipmaker closes its $8.2 billion purchase of her startup. Her story runs through Chengdu, a Parsippany dry cleaner and a teacher who gave up his lunch hour.
- Astronomy · Sat.
ESA released Euclid DR1-Foundation on Nov. 12, 2026: about 13 months of data, more than a billion objects over an area of 9,500 full Moons (1,900 sq deg main survey, 1.7 million GB), around 15,000 strong-lens candidates, more than 60 million quasar candidates and spectra for 160 million sources. About 14% of Euclid's planned survey; full DR1 due mid-2027. Data public on Euclid Data Space.
- Government · Sat.
The Sunnyvale City Council meets Tuesday, Nov. 17, at 7 p.m. to decide whether to plan a 40-unit interim housing community at 1240 Fair Oaks Way and start an RV permit parking program on Caribbean Drive.